Medi-Caps Limited carries a market capitalization of 328.71M, placing it among publicly traded companies globally. Its enterprise value stands at 50.67M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 328.71M |
| Enterprise Value | 50.67M |
Medi-Caps Limited currently has 12.47M shares outstanding.
| Shares Outstanding | 12.47M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 2.34, and the price-to-book ratio stands at 2.32.
| PE Ratio | N/A |
| PS Ratio | 2.34 |
| PB Ratio | 2.32 |
| P/TBV Ratio | 0.35 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
| EV / Sales | 0.41 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 387.95 |
Medi-Caps Limited maintains a current ratio of 17.34, meaning it holds 17.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 17.34 |
| Quick Ratio | 8.82 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -862.94 |
| Return on Equity (ROE) | -24.36 |
| Return on Assets (ROA) | -2.52 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.84 |
| Income Tax | 141,000.00 |
| Effective Tax Rate | N/A |
Medi-Caps Limited's stock has declined approximately -39.61054% over the past 52 weeks. The 50-day moving average sits at 28.40, while the 200-day moving average is 30.35.
| Beta (5Y) | N/A |
| 52-Week Price Change | -39.61054% |
| 50-Day Moving Average | 28.40 |
| 200-Day Moving Average | 30.35 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Medi-Caps Limited generated 123.96M in revenue and converted that into -30.37M in net income, yielding earnings per share of -2.43. EBITDA reached -112.18M, while operating income came in at -112.18M.
| Revenue | 123.96M |
| Gross Profit | 67.57M |
| Operating Income | -112.18M |
| Pretax Income | -30.23M |
| Net Income | -30.37M |
| EBITDA | -112.18M |
| EBIT | -112.18M |
| Earnings Per Share (EPS) | -2.43 |
Total book value stands at 124.70M, with working capital of 443.13M providing operational flexibility.
| Cash & Cash Equivalents | 239.14M |
| Total Debt | N/A |
| Net Debt | -5.03M |
| Equity (Book Value) | 124.70M |
| Book Value Per Share | 9.98 |
| Working Capital | 443.13M |
Medi-Caps Limited operates with a gross margin of 54.51, reflecting its pricing power and cost economics. The operating margin of -90.50 and net profit margin of -24.50 provide insight into operational efficiency.
| Gross Margin | 54.51 |
| Operating Margin | -90.50 |
| Pretax Margin | -24.39 |
| Profit Margin | -24.50 |
| EBITDA Margin | -90.50 |
Medi-Caps Limited's most recent stock split took place on March 19, 2013 with a 1:4 split ratio.
| Last Split Date | 3/19/2013 |
| Split Ratio | 1:4 |
Medi-Caps Limited posts an Altman Z-Score of 4.84, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.84 |